Equities

Sinohealth Holdings Ltd

Sinohealth Holdings Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)4.70
  • Today's Change0.00 / 0.00%
  • Shares traded20.50k
  • 1 Year change+1.08%
  • Beta--
Data delayed at least 15 minutes, as of Aug 30 2024 08:56 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Sinohealth Holdings Ltd grew revenues 11.08% from 356.67m to 396.19m while net income improved 82.99% from 55.76m to 102.03m.
Gross margin57.71%
Net profit margin23.45%
Operating margin25.83%
Return on assets11.59%
Return on equity13.65%
Return on investment13.46%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Sinohealth Holdings Ltd fell by 285.39m. However, the company earned 79.06m from its operations for a Cash Flow Margin of 19.95%. In addition the company used 234.20m on investing activities and also paid 132.53m in financing cash flows.
Cash flow per share0.2737
Price/Cash flow per share18.50
Book value per share1.75
Tangible book value per share1.72
More ▼

Balance sheet in CNYView more

Sinohealth Holdings Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio5.26
Quick ratio5.20
Total debt/total equity0.0203
Total debt/total capital0.02
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 87.48% and 76.36%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Business Services industry pay a dividend.
Div yield(5 year avg)0.41%
Div growth rate (5 year)--
Payout ratio (TTM)31.29%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-8.90
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.